Clinical Trial Update: Human Albumin Treatment in Adult Septic Shock. A Study Evaluating Immune Response and Organ Failure. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating human albumin treatment in adults with septic shock has been withdrawn. The sponsor is Albimmune SL.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Human Albumin

Snippet

Sponsor: Albimmune SL | Conditions: Septic Shock | Phase 2 | Status: WITHDRAWN